Patents by Inventor Andreas GALLEI

Andreas GALLEI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Infectious CDNA clone of european PRRS virus and uses thereof
    Patent number: 9315781
    Abstract: The present invention belongs to the field of animal health and relates to a nucleic acid sequence which comprises the genome of an infectious genotype I (EU) PRRS virus clone useful for studying Porcine Reproductive and Respiratory Syndrome (PRRS), a viral disease affecting swine, and in the development of vaccines, therapeutics and diagnostics for the prophylaxis, treatment and diagnosis of PRRS.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: April 19, 2016
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Christiane Fetzer, Andreas Gallei
  • NOVEL PRRS VIRUS INDUCING TYPE I INTERFERON IN SUSCEPTIBLE CELLS
    Publication number: 20160040136
    Abstract: The present invention relates to the field of attenuated live viruses useful as vaccine or medicament for preventing or treating Porcine Reproductive and Respiratory Syndrome (PRRS) in swine, and is based on the surprising finding of a PRRS virus which is able to induce the interferon type I response of a cell infected by said virus. In one embodiment, the PRRS virus according to the invention is a PRRS virus mutant comprising, in comparison with the genome of a wild type strain, a mutation in the gene encoding the non structural protein 1 (nsp1) of said virus.
    Type: Application
    Filed: October 12, 2015
    Publication date: February 11, 2016
    Inventor: Andreas GALLEI
  • PRRS virus inducing type I interferon in susceptible cells
    Patent number: 9187731
    Abstract: The present invention relates to the field of attenuated live viruses useful as vaccine or medicament for preventing or treating Porcine Reproductive and Respiratory Syndrome (PRRS) in swine, and is based on the surprising finding of a PRRS virus which is able to induce the interferon type I response of a cell infected by said virus. In one embodiment, the PRRS virus according to the invention is a PRRS virus mutant comprising, in comparison with the genome of a wild type strain, a mutation in the gene encoding the non structural protein 1 (nsp1) of said virus.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: November 17, 2015
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventor: Andreas Gallei
  • NOVEL PRRS VIRUS INDUCING TYPE I INTERFERON IN SUSCEPTIBLE CELLS
    Publication number: 20130028931
    Abstract: The present invention relates to the field of attenuated live viruses useful as vaccine or medicament for preventing or treating Porcine Reproductive and Respiratory Syndrome (PRRS) in swine, and is based on the surprising finding of a PRRS virus which is able to induce the interferon type I response of a cell infected by said virus. In one embodiment, the PRRS virus according to the invention is a PRRS virus mutant comprising, in comparison with the genome of a wild type strain, a mutation in the gene encoding the non structural protein 1 (nsp1) of said virus.
    Type: Application
    Filed: July 26, 2012
    Publication date: January 31, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventor: Andreas GALLEI